4th Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.RES.97 : A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs. S. 959, Pharmaceutical Compounding Quality and Accountability Act S. 957, Drug Supply Chain Security Act H.R.3204 Drug Quality and Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.